RheumMadness   

Do you have thoughts in general about the potential of TYK2 inhibition for these difficult to treat diseases?This question is part of a collaboration ...

This question is part of a collaboration with RheumMadness and is specifically in reference to: Cost Effectiveness of HCQ Screening.

What key factors will you consider when selecting patients for this therapy?This question is part of a collaboration with RheumMadness and i...

This question is part of a collaboration with RheumMadness and is specifically in reference to: Obinutuzumab in Lupus Nephritis

This question is part of a collaboration with RheumMadness and is specifically in reference to: Steroid Dose in Lupus Nephritis

This question is part of a collaboration with RheumMadness and is specifically in reference to: Long-term outcomes of anifrolumab in SLE.

This question is part of a collaboration with RheumMadness and is specifically in reference to: Bissonnette et al., PMID 38324484

This question is part of a collaboration with RheumMadness and is specifically in reference to: ULT During Gout Flare.

What disease activity index do you find more useful and most practical in a busy clinical setting? How often do you assess it?This question is part of...

This question is part of a collaboration with RheumMadness and is specifically in reference to: Antibodies Before SLE.

This question is part of a collaboration with RheumMadness and is in reference to Pathogenic ANCA (RAVE Trial).

Do you prefer to start with nintedanib and then add immunosuppressive agents, or give a trial of immunosuppressive medication first, then add nintedan...

This question is part of a collaboration with RheumMadness and is specifically in reference to: Hydroxychloroquine Withdrawal.

This question is part of a collaboration with RheumMadness and is specifically in reference to: EMBRACE

This question is part of a collaboration with RheumMadness and is specifically in reference to: ADIRA Diet